Athersys, Inc. (ATHX) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up nearly 49% in the past one-month time frame.
The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Athersys currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some other stocks worth considering in the BioTech sector include Gentium S.p.A (GENT), Achillion Pharmaceuticals, Inc. (ACHN) and Alimera Sciences, Inc. (ALIM). While Gentium holds a Zacks Rank #1 (Strong Buy), Achillion and Alimera carry the same Zacks Rank as Athersys.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ATHERSYS INC (ATHX): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
ACHILLION PHARMACEUTICALS INC (ACHN): Free Stock Analysis Report
ALIMERA SCIENCES INC (ALIM): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies